Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Medifast, Inc. is a U.S.-based health and wellness company primarily operating in the weight management and nutrition industry. The company designs, manufactures, and distributes clinically guided weight-loss programs and nutritional products, with revenue historically driven by the OPTAVIA lifestyle intervention program. Medifast serves individual consumers seeking weight loss, weight management, and healthy living solutions, primarily through a direct-to-consumer and coach-supported distribution model.
The company was founded in 1980 and initially focused on medically supervised weight-loss products sold through healthcare professionals. Over time, Medifast evolved toward a multi-level coaching and direct-selling structure, culminating in the launch and growth of OPTAVIA, which became its dominant brand and revenue source. This strategic shift significantly reshaped the company’s operating model and market positioning, emphasizing personalized coaching, behavioral change, and recurring product consumption.
Business Operations
Medifast operates primarily through a single reportable segment centered on OPTAVIA, which integrates packaged nutritional products, structured weight-loss plans, and independent health coaches. Revenue is generated through the sale of branded meal replacements, snacks, and nutritional supplements, largely purchased by clients and facilitated by a network of independent OPTAVIA Coaches. The company manages product formulation, quality control, and branding, while manufacturing is handled through third-party contract manufacturers.
Operations are predominantly domestic, with the vast majority of revenue generated in the United States. Medifast maintains centralized corporate functions including marketing, supply chain oversight, and digital platform management. The company controls proprietary program frameworks and intellectual property related to its weight-loss methodologies but does not own large-scale manufacturing facilities.
Strategic Position & Investments
Medifast’s strategic direction has focused on expanding the OPTAVIA ecosystem through coach acquisition, digital tools, and program enhancements aimed at improving client retention and outcomes. Growth initiatives have included investments in technology platforms that support coach-client engagement, data analytics, and personalized health journeys. The company has also emphasized product innovation within its nutritional offerings to align with evolving consumer preferences and regulatory standards.
Historically, Medifast has pursued limited acquisition activity, favoring organic growth rather than large-scale mergers or portfolio diversification. Its investments have largely centered on internal capabilities, brand development, and operational efficiency. Exposure to emerging sectors such as digital health and behavior-based wellness is primarily indirect and integrated within the OPTAVIA platform rather than through standalone subsidiaries.
Geographic Footprint
Medifast is headquartered in Baltimore, Maryland, and its core operations and customer base are concentrated in North America, particularly the United States. The OPTAVIA program has had limited international presence, with select activity in Asia-Pacific markets through localized coach networks, though international revenue has historically represented a small portion of total sales.
The company’s operational influence outside the U.S. is modest, with no significant manufacturing or corporate offices abroad. International expansion has been approached cautiously, focusing on regulatory compliance and scalable demand before deeper investment.
Leadership & Governance
Medifast is led by an executive team with experience in direct selling, consumer health, and brand-driven growth. The company emphasizes a leadership philosophy centered on mission-driven culture, ethical coaching practices, and long-term client health outcomes. Governance is overseen by a board of directors with backgrounds in consumer products, healthcare, and corporate finance.
Key executives include:
- Daniel R. Chard – Chief Executive Officer
- Jim Maloney – Chief Financial Officer
- Kory Bishop – Chief Operating Officer
- Dr. Wayne Andersen – Co-Founder of OPTAVIA and Chief Medical Officer
- Kevin Moran – Chief Marketing Officer
Leadership strategy has consistently highlighted disciplined cost management, brand integrity, and the scalability of the coach-supported model while navigating changing consumer demand and regulatory scrutiny in the weight management sector.